Search

Your search keyword '"Akarca, Ulus S"' showing total 142 results

Search Constraints

Start Over You searched for: Author "Akarca, Ulus S" Remove constraint Author: "Akarca, Ulus S"
142 results on '"Akarca, Ulus S"'

Search Results

1. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

2. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

3. Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

4. Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

5. Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

6. Five years follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

7. Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.

8. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

9. Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2a treatment of hepatitis D: An analysis of the HIDIT‐II trial.

12. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020:a modelling study

15. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real‐world chronic hepatitis C patients cohort

16. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience

19. SAT-152 - Five years follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D

20. Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: results from the HIDIT-II study

21. Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta

22. Recommendation for treatment of hepatitis C virus infection

23. A transient early HBV‐DNA increase during PEG‐IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV‐RNA and HBsAg reduction

24. Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta: Results from the HIDIT‐II study

26. Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study: 24

28. Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta

29. Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study

34. Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study

36. Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta: Results from the HIDIT‐II study.

37. A transient early HBV‐DNA increase during PEG‐IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV‐RNA and HBsAg reduction.

38. Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Om-bitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience.

40. Recommendation for treatment of hepatitis C virus infection

43. KRONİK C HEPATİTİNDE HİSTOPATOLOJİK ÖZELLİKLER: KRONİK B HEPATİTİ İLE KARŞILAŞTIRMALI BİR ÇALIŞMA

44. Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a

47. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

49. Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

50. Recipient-Derived Hepatocytes in Sex-Mismatched Liver Allografts after Liver Transplantation: Early versus Late Transplant Biopsies

Catalog

Books, media, physical & digital resources